Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

NOL11 Inhibitors

NOL11 inhibitors are chemical compounds designed to specifically interact with and modulate the activity of the NOL11 protein, which plays a critical role in ribosome biogenesis. NOL11, also known as nucleolar protein 11, is involved in the processing of 47S pre-rRNA into mature 18S, 5.8S, and 28S rRNAs, essential for proper ribosomal assembly. This protein is located primarily within the nucleolus, where it contributes to the formation and maturation of ribosomal RNA, a fundamental process for protein synthesis. Inhibitors targeting NOL11 are typically designed to interfere with this ribosomal RNA processing pathway by either binding directly to NOL11 or by interacting with its cofactors, thereby disrupting its function and causing a cascade of effects that impair ribosome formation.

Structurally, NOL11 inhibitors tend to exhibit high specificity for their target protein due to the complexity and importance of the nucleolar processes they influence. These inhibitors may feature molecular frameworks that enable them to penetrate the nucleolus efficiently and bind with precision to NOL11's active or allosteric sites. The inhibition of NOL11 affects the stability of pre-rRNA intermediates and can halt the progression of rRNA maturation, ultimately influencing protein synthesis. By targeting such a central element in the cellular machinery, these compounds can induce a range of downstream cellular effects, depending on the extent of inhibition and the cell type. The development and study of NOL11 inhibitors provide insight into the regulation of nucleolar functions and ribosome biogenesis, offering a molecular tool for probing the dynamics of RNA processing within the cell.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

Inhibits CRM1/exportin 1, potentially altering nuclear-cytoplasmic transport of proteins, including those interacting with NOL11.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interferes with DNA-dependent RNA synthesis potentially affecting the transcription of genes related to NOL11 function.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Inhibits transcriptional activity by affecting RNA polymerase II, possibly impacting NOL11 expression.

KPT 330

1393477-72-9sc-489062
5 mg
$173.00
(0)

Inhibits XPO1/CRM1, potentially affecting nuclear export signals and influencing proteins that interact with NOL11.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

Targets the spliceosome, potentially affecting splicing of pre-mRNA of genes that code for proteins interacting with NOL11.

Spliceostatin A

391611-36-2sc-507481
1 mg
$1800.00
(0)

Binds to the spliceosome, potentially affecting splicing factors and proteins that interact with NOL11.

Ispinesib

336113-53-2sc-364747
10 mg
$505.00
(0)

Inhibits kinesin spindle protein (KSP), potentially disrupting mitosis which can affect cell division-related proteins including NOL11.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Inhibits N-linked glycosylation, potentially affecting the folding and stability of proteins that may interact with NOL11.

MLN8237

1028486-01-2sc-394162
5 mg
$220.00
(0)

Inhibits Aurora A kinase, potentially affecting cell cycle progression and proteins associated with NOL11 function.

Homoharringtonine

26833-87-4sc-202652
sc-202652A
sc-202652B
1 mg
5 mg
10 mg
$52.00
$125.00
$182.00
11
(1)

Inhibits protein synthesis, potentially reducing the availability of proteins that interact with NOL11.